CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 82 enrolled
Drug / intervention
Adductor Canal Block (ACB) Only +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05498870
NCT05498870Phase 4Completed

Studying the Effects of iPACK Blocks With Adductor Canal Blocks for Postoperative Analgesia Following ACL Reconstruction

Medical University of South Carolina·interventional·Posted Aug 12, 2022·Updated Oct 16, 2024

In Brief

A Phase 4 clinical trial evaluating Adductor Canal Block (ACB) Only and Adductor Canal Block (ACB) + iPACK Block for ACL Injury and Post Operative Pain. Completed, enrolled 82 participants across 1 site.

Detailed Summary

This study will consist of patients 12 years and older undergoing ACL reconstruction using a quadriceps or bone-patella tendon bone (BTB) graft. The patients will be randomized to adductor canal block alone, or adductor canal block + iPACK block. The primary goal will be to determine the differences in postoperative pain during the first 72 hours when comparing the two groups. Secondary outcomes will include opioid utilization during the first 72 hours postoperatively and range of motion including terminal knee extension at postoperative follow-up visits.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2023202420252026
First PostedAug 12, 2022
Enrollment StartAug 25, 2022
Primary CompletionJul 3, 2023
Study CompletionAug 14, 2023
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 3.9 years ago

Interventions

Adductor Canal Block (ACB) Onlydrug

Patients will receive an ACB with lidocaine skin wheal

Adductor Canal Block (ACB) + iPACK Blockdrug

Patients will receive an ACB with iPACK block